Context Therapeutics Inc. (CNTX)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch CNTX
Latest sale
None
No Form 4 sale on record
Form 4 sales
0
On record
Form 144 notices
0
Proposed sales
Sold, last 30 days
None
No Form 4 sale
Sold, last 90 days
None
No Form 4 sale
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

No Form 4 sale on record.

Timeline

No filings yet.

Every transaction

Every transaction on a Form 4 or Form 5 for CNTX
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Jun 24, 2026Jun 26, 2026CNTXPasternak AndyDirectorAwardedStock Option (right to buy)45,00045,000SEC
Jun 24, 2026Jun 26, 2026CNTXStacey Jennifer EvansDirectorAwardedStock Option (right to buy)45,00045,000SEC
Jun 24, 2026Jun 26, 2026CNTXWest LindaDirectorAwardedStock Option (right to buy)45,00045,000SEC
Jun 24, 2026Jun 26, 2026CNTXSmith Karen L.DirectorAwardedStock Option (right to buy)45,00045,000SEC
Jun 24, 2026Jun 26, 2026CNTXWalker Luke NathanielDirectorAwardedStock Option (right to buy)45,00045,000SEC
Jun 24, 2026Jun 26, 2026CNTXKantoff Philip W.DirectorAwardedStock Option (right to buy)45,00045,000SEC
Feb 19, 2026Feb 23, 2026CNTXLevit Alex C.Chief Legal Officer, Corp. SecAwardedStock Option (right to buy)270,000270,000SEC
Feb 19, 2026Feb 23, 2026CNTXMinai-Azary Jennifer LynnChief Financial OfficerAwardedStock Option (right to buy)275,000275,000SEC
Feb 19, 2026Feb 23, 2026CNTXChagin Karen DeborahChief Medical OfficerAwardedStock Option (right to buy)290,000290,000SEC
Feb 19, 2026Feb 23, 2026CNTXLehr Martin A.Chief Executive OfficerAwardedStock Option (right to buy)815,000815,000SEC
Jun 12, 2025Jun 12, 2025CNTXPasternak AndyDirectorAwardedStock Option (right to buy)138,900138,900SEC
Jun 12, 2025Jun 12, 2025CNTXKantoff Philip W.DirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 12, 2025Jun 12, 2025CNTXSmith Karen L.DirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 12, 2025Jun 12, 2025CNTXStacey Jennifer EvansDirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 12, 2025Jun 12, 2025CNTXWalker Luke NathanielDirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 12, 2025Jun 12, 2025CNTXWest LindaDirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 9, 2025Jun 10, 2025CNTXLehr Martin A.Chief Executive OfficerBought100,000$0.70$70k920,190SEC
Jun 9, 2025Jun 9, 2025CNTXChagin Karen DeborahChief Medical OfficerAwardedStock Option (right to buy)153,000153,000SEC
Jun 6, 2025Jun 10, 2025CNTXLevit Alex C.Chief Legal Officer, Corp. SecBought20,000$0.58$12k29,000SEC
Jun 6, 2025Jun 10, 2025CNTXMinai-Azary Jennifer LynnChief Financial OfficerBought40,010$0.64$26k80,010SEC
Feb 13, 2025Feb 14, 2025CNTXMinai-Azary Jennifer LynnChief Financial OfficerAwardedStock Option (right to buy)371,800371,800SEC
Feb 13, 2025Feb 14, 2025CNTXLevit Alex C.Chief Legal Officer, Corp. SecAwardedStock Option (right to buy)349,900349,900SEC
Feb 13, 2025Feb 14, 2025CNTXDansky Ullmann ClaudioChief Medical OfficerAwardedStock Option (right to buy)174,960174,960SEC
Feb 13, 2025Feb 14, 2025CNTXLehr Martin A.Chief Executive OfficerAwardedStock Option (right to buy)802,700802,700SEC
Jan 13, 2025Jan 14, 2025CNTXPasternak AndyDirectorAwardedStock Option (right to buy)20,68520,685SEC
Sep 4, 2024Sep 5, 2024CNTXSmith Karen L.DirectorAwardedStock Option (right to buy)19,31519,315SEC
Sep 4, 2024Sep 5, 2024CNTXWalker Luke NathanielDirectorAwardedStock Option (right to buy)19,31519,315SEC
Aug 1, 2024Aug 1, 2024CNTXDansky Ullmann ClaudioChief Medical OfficerAwardedStock Option (right to buy)202,170202,170SEC
Jun 13, 2024Jun 14, 2024CNTXStacey Jennifer EvansDirectorAwardedStock Option (right to buy)25,00025,000SEC
Jun 13, 2024Jun 14, 2024CNTXKantoff Philip W.DirectorAwardedStock Option (right to buy)25,00025,000SEC
Jun 13, 2024Jun 14, 2024CNTXWest LindaDirectorAwardedStock Option (right to buy)25,00025,000SEC
Jun 13, 2024Jun 14, 2024CNTXBerman Richard JDirectorAwardedStock Option (right to buy)50,00050,000SEC
Mar 21, 2024Mar 22, 2024CNTXMinai-Azary Jennifer LynnChief Financial OfficerAwardedStock Option (right to buy)160,115160,115SEC
Mar 21, 2024Mar 22, 2024CNTXLevit Alex C.Chief Legal Officer, Corp. SecAwardedStock Option (right to buy)153,515153,515SEC
Mar 21, 2024Mar 22, 2024CNTXLehr Martin A.Chief Executive OfficerAwardedStock Option (right to buy)291,402291,402SEC
May 31, 2023May 31, 2023CNTXKantoff Philip W.DirectorAwardedStock Option (right to buy)25,00025,000SEC
May 31, 2023May 31, 2023CNTXWest LindaDirectorAwardedStock Option (right to buy)25,00025,000SEC
May 31, 2023May 31, 2023CNTXStacey Jennifer EvansDirectorAwardedStock Option (right to buy)25,00025,000SEC
May 31, 2023May 31, 2023CNTXBerman Richard JDirectorAwardedStock Option (right to buy)50,00050,000SEC
Feb 21, 2023Feb 21, 2023CNTXLehr Martin A.Chief Executive OfficerBought5,823$0.84$5k159,701SEC
Feb 13, 2023Feb 14, 2023CNTXLevit Alex C.Chief Legal Officer, Corp. SecAwardedStock Option (right to buy)151,505151,505SEC
Feb 13, 2023Feb 14, 2023CNTXLehr Martin A.Chief Executive OfficerAwardedStock Option (right to buy)287,544287,544SEC
Feb 13, 2023Feb 14, 2023CNTXMinai-Azary Jennifer LynnChief Financial OfficerAwardedStock Option (right to buy)158,001158,001SEC
Feb 13, 2023Feb 13, 2023CNTXLehr Martin A.Chief Executive OfficerBought5,606$0.87$5k153,878SEC
Feb 6, 2023Feb 6, 2023CNTXLehr Martin A.Chief Executive OfficerBought5,040$0.97$5k148,272SEC
Jan 30, 2023Jan 30, 2023CNTXLehr Martin A.Chief Executive OfficerBought7,027$0.70$5k143,232SEC
Jan 23, 2023Jan 23, 2023CNTXLehr Martin A.Chief Executive OfficerBought6,839$0.72$5k136,205SEC
Jan 17, 2023Jan 18, 2023CNTXLehr Martin A.Chief Executive OfficerBought6,783$0.74$5k129,366SEC
Dec 16, 2022Dec 19, 2022CNTXMinai-Azary Jennifer LynnChief Financial OfficerBought25,000$0.74$19k40,000SEC
Dec 16, 2022Dec 19, 2022CNTXLehr Martin A.Chief Executive OfficerBought20,000$0.74$15k122,583SEC
Page 1